Despite upregulation of AT1R and P2X 1 R in hypertension, Up 4 Amediated aortic contraction was impaired in Ang II-infused mice, likely through the desensitization of P2X 1 R but not AT1R. This implies that vascular P2X 1 R activity, rather than plasma Up 4 A level, may determine the role of Up 4 A in hypertension.
Original article
Arterial hypertension, a persistent elevation in blood pressure, is a major health problem and risk factor for several cardiovascular diseases. 1, 2 One of the mechanisms underlying elevated blood pressure is increased vascular tone, mainly due to an impaired balance between vasoconstrictors and vasodilators. 1, 3 Among the vasoconstrictors, increased plasma angiotensin II (Ang II), exerting its vasoconstrictor influence via type 1 receptors (AT1R), 4 is a key factor contributing to increased vasoconstriction, thereby playing a crucial role in the development of hypertension. 1, 2 Uridine adenosine tetraphosphate (Up 4 A) was initially identified as a novel vasoconstrictor endogenously released from the endothelium. 5 Several in vitro studies showed that Up 4 A-induced vascular contraction in various vascular beds through the activation of purinergic receptors.
Vasoconstriction was observed in rat renal arteries through P2X 1 R, 5 rat aortas through P1R and P2XR, 6 and rat pulmonary arteries through P2YR. 7 Vasoconstriction was also observed in mouse renal arterioles 8 and rat mesenteric arteries, 9 although Up 4 A was subsequently found to exert a vasodilator influence in rat aortas, 6 isolated perfused kidney, 10 porcine coronary arteries, 11, 12 and human and mouse colon. 13 Notably, the observations that intra-aortic injection of Up 4 A increased mean arterial blood pressure in intact animals 5 and plasma concentrations of Up 4 A detected in juvenile hypertensive subjects were significantly elevated 14 suggested a role for Up 4 A-purinergic receptor signaling in the pathogenesis of hypertension.
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OBJECTIVE
We previously showed that uridine adenosine tetraphosphate (Up 4 A)-mediated aortic contraction is partly mediated through purinergic P2X 1 receptors (P2X 1 R). It has been reported that the plasma level of Up 4 A is elevated in hypertensive patients, implying a potential role for Up 4 A-P2X 1 R signaling in hypertension. This study investigated the vasoactive effect of Up 4 A in aortas isolated from angiotensin (Ang) II-infused (21 days) hypertensive mice.
METHODS
Blood pressure was measured by tail cuff plethysmography. Aortas were isolated for isometric tension measurements, and protein expression was analyzed by western blot.
RESULTS
Mean and systolic arterial pressures were elevated by ~50% in Ang II-infused mice. Protein levels of both AT1R and P2X 1 R were upregulated in Ang II-infused aortas. Surprisingly, Up 4 A (10 −9 -10 −5 M)-induced concentration-dependent contraction was significantly impaired in Ang II-infused mice. Studies in control mice revealed that both P2X 1 R (MRS2159) and AT1R (losartan) antagonists significantly attenuated Up 4 A-induced aortic contraction. In addition, desensitization of AT1R by prior Ang II (100 nM) exposure had no effect on Up 4 A-induced aortic contraction. However, subsequent serial exposure responses to Up 4 A-induced aortic contraction were markedly reduced, suggesting a desensitization of purinergic receptors. This desensitization was further confirmed in control mice by prior exposure of aortas to the P2X 1 R desensitizer α, β-methylene ATP (10 μM).
partly through activation of P2X 1 R. 15 Importantly, P2X 1 R was upregulated in the rat renal cortex of Ang II-induced hypertension. 16 Overall, these findings suggest that the vasoconstrictor influence of Up 4 A could be increased in hypertension, contributing to high blood pressure. Consequently, we further studied whether Up 4 A-P2X 1 R signaling was altered in aortas of Ang II-induced hypertension with a hypothesis that the vasoconstrictor effect of Up 4 A and expression of P2X 1 R are increased in aortas isolated from chronic Ang II-infused mice. Increased plasma levels of both Ang II and Up 4 A, 14, 17 along with upregulation of AT1R in aorta of diabetic spontaneously hypertensive rats 18 and P2X 1 R, 16 have been reported in hypertension. This implies a possible crosstalk between Up 4 A and Ang II pathways. Thus, an additional aim of our study was to explore the involvement of AT1R in Up 4 A-mediated vascular contraction in wild type (control) mouse aortas. Our findings indicate that, despite the upregulation of AT1R and P2X 1 R, Up 4 A-mediated aortic contraction was surprisingly impaired in hypertensive mice. Furthermore, this impaired vascular contraction could be due to desensitization of P2X 1 R but not AT1R.
METHODS
All experimental protocols were approved by the Institutional Animal Care and Use Committee of West Virginia University. Expanded method descriptions are available in the Supplementary Material.
Animals
Male mice (C57BL/6 background, WT) were used in the present study. To induce hypertension, WT mice (at the age of 17 weeks) received either Ang II (1,000 ng kg −1 min −1 ) 19 or vehicle (saline) infusion for 3 weeks via a subcutaneously implanted Alzet osmotic mini-pump. Blood pressure was measured using the noninvasive CODA-8 (Kent Scientific) 20 tail cuff system before (at day 0) and throughout the 3-week (day 21) Ang II or saline infusion. For some experiments, mice (14 to 16 weeks) without any infusions were regarded as the control group throughout the entire manuscript.
Tissue preparation and isometric force measurement
Mice were euthanized by anesthesia with pentobarbital sodium (65 mg/kg i.p.) followed by thoracotomy and removal of aortas. The aortas were isolated and subjected to isometric force measurement as described 15 previously (see supplemental material for details).
Organ bath experimental protocols
Up 4 A concentration-response (10 −9 -10 −5 M) curves were acquired in preconstricted aortas from saline-and Ang II-infused mice. To characterize the receptor involvement, aortic rings were subjected to increasing Up 4 A concentrations (10 −9 -10 −5 M) in the absence and presence of the P2X 1 R antagonist MRS2159 (30 μM) 15, 21 and the AT1R antagonist losartan (10 μM) 22 in control mice. To investigate the possible effect of AT1R desensitization on Up 4 A influence, Up 4 A concentration-response (10 −9 -10 −5 M) curves were acquired in the absence and presence of prior exposure to Ang II (100 nM) in isolated aortic rings of control mice. 23 The Ang II-induced AT1R desensitization was checked by the subsequent Ang II exposure 30 minutes later. To study the possible purinergic receptor desensitization in response to Up 4 A, 2-time Up 4 A concentration-response (10 −9 -10 −5 M) curves were acquired with a 30-minute interval in the same preparation. To further confirm the purinergic receptor desensitization, Up 4 A concentration-response (10 −9 -10 −5 M) curves were acquired in the absence and presence of the P2X 1 R desensitizer α, β-methylene ATP (10 μM) in isolated aortic rings of control mice. 10, 24 
Western blotting
Western blot analyses were performed as described earlier. [25] [26] [27] Primary antibodies for AT1R and P2X 1 R (1:1,000) were incubated overnight, followed by incubation with secondary antibodies for 1 hour (goat anti-rabbit 1:10,000 dilution for both AT1R and P2X 1 R).
Statistical analysis
Vascular contraction responses to Up 4 A were expressed as percentage of contraction to PE or KCl. The effects of drug treatment on the Up 4 A concentration responses were assessed using 2-way analysis of variance for repeated measures. Comparisons for mean arterial blood pressure and systolic blood pressure were analyzed using 1-way analysis of variance. Comparisons between 2 groups were analyzed using unpaired t-tests. Statistical significance was accepted when P < 0.05 (2-tailed). Data are presented as mean ± SEM.
RESULTS

Impaired Up 4 A-induced vascular contraction in aortas from hypertensive mice
Mean arterial blood pressure was (in mm Hg) 81 ± 3 in the saline-infused group and 80 ± 2 in the Ang II-infused group at day 0 that increased by ~50% in Ang II-infused mice (126 ± 7) as compared to saline-infused mice (80 ± 2) at day 21 ( Figure 1A ). Systolic blood pressure in salineinfused mice was (in mm Hg) 101 ± 7 at day 0 and 101 ± 8 at day 21, while in Ang II-infused mice, systolic blood pressure was 101 ± 8 at day 0 that significantly increased to 152 ± 21 at day 21 ( Figure 1B ). AT1R and P2X 1 R protein levels in isolated aortas were markedly elevated after a 3-week infusion of Ang II as compared to saline ( Figure 1C -E). P2X 1 R has been reported to play a role in hypertension 16 and is involved in Up 4 A-mediated contraction in healthy vessels. 15, 28 These findings indicate that Ang II-infused mice were hypertensive in conjunction with higher AT1R and P2X 1 R expressions.
Muscle tension measurement data revealed no significant differences in 1 μM PE-(0.24 ± 0.03 g vs. 0.29 ± 0.04 g; P > 0.05) and 50 mM KCl-induced contractions (0.32 ± 0.04 g vs. 0.29 ± 0.04 g; P > 0.05) or 1 μM ACh-induced relaxation (52.0 ± 0.9% vs. 60.3 ± 5.5%; P > 0.05) in isolated aortas between saline-and Ang II-infused mice. Reduced ACh concentration response-induced relaxation was observed in aortas of Ang II-infused mice (Supplementary Figure 1) . At baseline, Up 4 A produced a mild aortic contraction in salineinfused mice, which was slightly but significantly reduced in Ang II-infused mice (Supplementary Figure 2) . In accordance with our previous study, 15 Up 4 A produced a concentration-dependent aortic contraction >70% upon PE-induced steady contraction in saline-infused mice (Figure 2A and B). Surprisingly, this vasoconstrictor effect was significantly impaired in Ang II-infused mice irrespective of the contraction normalized to PE (maximal contraction: 74.3 ± 8.2% in saline vs. 46.5 ± 5.7% in Ang II group, Figure 2A ) or KCl (maximal contraction: 77.9 ± 8.6% in saline vs. 57.9 ± 6.2% in Ang II group, Figure 2B ). In order to determine whether saline infusion had any effect on Up 4 A responses, we performed Up 4 A concentration responses in aortas of saline-infused and control mice. There was no significant difference in Up 4 Ainduced vascular contraction in isolated aortas between the 2 groups of mice (maximal contraction: 76.7 ± 7.1% in saline vs. 74.5 ± 7.2% in control group, Figure 2C ), suggesting that chronic saline infusion did not affect the Up 4 A response.
Involvement of AT1R and P2X 1 R in Up 4 A-mediated vascular contraction in mouse aortas
Our observations that both AT1R and P2X 1 R were upregulated in hypertensive mice ( Figure 1D and E) suggested a possible link between the 2 pathways. We next performed Up 4 A-concentration-dependent contraction responses in isolated aortas of control mice in the absence and presence of AT1R or P2X 1 R antagonists. In agreement with our previous findings, 15 Up 4 A-induced aortic contraction was in part attenuated by the P2X 1 R antagonist, MRS2159 (maximal contraction: 70.2 ± 12.2% in control vs. 42.5 ± 7.2% in blocker group, Figure 2D ). Notably, Up 4 A-mediated aortic contraction was also significantly attenuated by the AT1R antagonist losartan (maximal contraction: 69.4 ± 12.7% in control vs. 29.5 ± 9.2% in blocker group, Figure 2E ). These observations indicate that P2X 1 R and AT1R are involved in Up 4 A-induced vascular contraction in mouse aortas.
Desensitization of P2X 1 R, but not AT1R, impairs Up 4 A-mediated aortic contraction in hypertension
Despite upregulation of AT1R and P2X 1 R in hypertension, Up 4 A-induced aortic contraction was impaired in Ang II-induced hypertensive mice (Figure 2A and B) . Since Up 4 A-induced aortic contraction is mediated through AT1R and P2X 1 R, we hypothesized that impaired vascular contraction induced by Up 4 A in hypertension was likely due to desensitization of AT1R and/or P2X 1 R. To address this, we performed acute experiments using control mice. Up 4 A concentration responses were obtained in the absence and presence of prior 2 exposures to Ang II ( Figure 3A) . The first Ang II exposure (100 nM) initiated aortic contraction up to 35% and waned several minutes later, while the second Ang II exposure failed to produce any contraction 30 minutes later (lower tracing in Figure 3A) , indicating a desensitization of AT1R. However, Up 4 A-induced vascular contraction produced after the desensitization of AT1R was comparable (maximal contraction: 81.1 ± 8.2%) to that produced without the desensitization of AT1R (maximal contraction: 69.4 ± 12.7%, Figure 3A and B). These observations indicate that AT1R desensitization had no effect on Up 4 A-induced aortic contraction.
We further investigated whether P2X 1 R desensitization played a role in an impaired vasoconstrictor response to Up 4 A. Two Up 4 A concentration-response curves were acquired with a 30-minue interval in the same preparation of control mice. The second Up 4 A concentration response produced much less vascular contraction (maximal contraction: 34.2 ± 11.1%) when compared to the first Up 4 A concentration response (maximal contraction: 83.3 ± 7.7%), indicating a desensitization of purinergic receptors ( Figure 4A and B). To rule out the involvement of differential PE-induced preconstriction, we compared PE-induced responses of serial Up 4 A stimulation. No significant differences between the 2 PE preconstrictions were observed (0.23 ± 0.04 g in the first PE response vs. 0.27 ± 0.04 g in the second PE response, P = 0.30, Figure 4C ). To further confirm the possible P2X 1 R desensitization, Up 4 A concentration curves were acquired in the absence and presence of a P2X 1 R desensitizer (α, β-methylene ATP). Up 4 A-induced aortic contraction was significantly reduced by α, β-methylene ATP (maximal contraction: 66.5 ± 10.6% in control vs. maximal contraction at 10 -6 M Up 4 A: 39.3 ± 12.5% in blocker group, Figure 4D ).
All together, these findings indicate that desensitization of P2X 1 R, but not AT1R, impairs Up 4 A-induced vascular contraction in isolated aortas. As a possible mechanism, 
DISCUSSION
The main findings of this study are: (i) chronic infusion of Ang II resulted in upregulation of AT1R and P2X 1 R protein levels in aortas; (ii) Up 4 A-induced aortic contraction was impaired in Ang II-infused mice; (iii) inhibition of AT1R and P2X 1 R attenuated Up 4 A-induced aortic contraction in control mice; (iv) desensitization of P2X 1 R, but not AT1R, played a role in impaired Up 4 A-induced aortic contraction. The implications of these findings are discussed below.
In accordance with previous findings, 29-31 chronic infusion of Ang II resulted in an increase in blood pressure in mice, which mimics many characteristics of essential hypertension in humans. 32 Particularly, the increase in blood pressure resulting from 1,000 ng/kg/min Ang II infusion for 21 days in the present study was consistent with other findings, 31 indicating that the hypertensive model was reproducible. This rise in blood pressure was due to the activation of AT1R by Ang II, as AT1R is the main Ang II receptor responsible for vascular contraction in most mouse vascular beds, including aortas. 4 Indeed, the increase in blood pressure was associated with an increase in AT1R protein expression in aortas after Ang II infusion. Through AT1R, Ang II activates various signaling pathways, such as NADPH-reactive oxygen species and endothelin-1. 33, 34 Interestingly, endothelin-1 has been shown to stimulate Up 4 A release from the endothelium 5 and the plasma concentrations of Up 4 A detected in healthy subjects are in the vasoactive range (~4 nM), 5 which can be markedly elevated in disease conditions such as hypertension (~33 nM in juvenile hypertensive patients). 14 Thus, it is reasonable to speculate that excess Up 4 A was released by endothelin-1 in our Ang II-infused model as compared to saline-infused. In isolated vessels or perfused organs, Up 4 A was initially identified as a novel endothelium-derived vasoconstrictor that exerts vascular contraction through activation of purinergic receptors. 5 Thus, vascular contraction was observed in rat renal arteries through P2X 1 R, 5 rat aortas through P1R and P2XR, 6 and rat pulmonary arteries through P2YR. 7 In agreement with our recent findings, 15 Up 4 A, with a potentially relevant concentration range (10 −9 -10 −5 M), produced vascular contraction in mouse aortas, which was attenuated by P2X 1 R antagonism. In addition to P2X 1 R, the vasoconstrictor effect may be mediated through other P2R subtypes, as we previously indicated that the nonselective P2R antagonist, which blocks most of P2R subtypes but not P2X 1 R, 10 attenuated Up 4 A-induced vascular contraction in mouse aortas. 15 Notably, the Up 4 A-mediated effect was also blunted by the AT1R antagonist losartan, at a concentration that completely blocked Ang II-induced mesenteric contraction in our previous study. 35 Similarly, treatment with losartan in diabetic rats has been reported to abolish nucleotides such as ATPmediated vascular contraction. 36 Importantly, in hypertension, Ang II and Up 4 A plasma levels have been reported to be elevated 14, 17 and expression of AT1R in aorta of diabetic spontaneously hypertensive rats 18 and P2X 1 R 16 has been upregulated. This concept regarding receptor upregulation in hypertension was further supported by our present findings that both AT1R and P2X 1 R protein levels were increased in isolated mouse aortas of Ang II-induced hypertension.
Studies revealed that intra-aortic injection of Up 4 A increased blood pressure in intact rats. 5 Furthermore, increased plasma Up 4 A concentration was reported in juvenile hypertensive patients. 5, 14 Together with these findings, we speculated that the vasoconstrictor effect of Up 4 A may be increased in hypertension, contributing to high blood pressure. Indeed, Matsumoto et al. showed that, in DOCAsalt-induced hypertensive rats, there was enhanced Up 4 Amediated vascular contraction in renal, basilar, and femoral arteries. 9, 37 In contrast, Up 4 A failed to affect vascular contraction in the thoracic aortas or pulmonary arteries of DOCA-salt-induced hypertensive rats. 9, 37 Moreover, Up 4 Ainduced vascular contraction in the mesenteric arteries of DOCA-salt-induced hypertensive rats was reduced, possibly due to the downregulation of P2X 1 R and P2Y 2 R. 9 In the present study, we found that Up 4 A-induced aortic contraction was significantly impaired in Ang II-induced hypertensive mice. The discrepancy in response to Up 4 A observed in our studies may be attributed to different hypertensive models. Both Ang II infusion and administration of DOCA-salt generate hypertensive models that involve common effectors, such as NADPH-reactive oxygen species, endothelin-1, and Ang II, leading to increases in blood pressure 33, 34 ; however, further studies are needed to address the effect of different characteristics of hypertensive models on Up 4 A-mediated vascular function. In addition, the differences in aortic contraction induced by Up 4 A may be attributed to the different species (mice vs. rats) studied, 38 as the expression and distribution of purinergic receptors may vary from species to species in the same vascular beds. 38, 39 Contrary to the observations that downregulation of P2X 1 R may contribute to reduced Up 4 A-mediated contraction in mesenteric arteries of DOCA-salt-induced hypertensive rats, 9 the upregulation of P2X 1 R does not appear to be responsible for the impaired Up 4 A-induced aortic contraction in our Ang II-infused mice. Together with our finding that Up 4 A-mediated aortic contraction is mediated through the activation of AT1R and P2X 1 R, possible explanations for impaired vascular contraction induced by Up 4 A in Ang II-infused mice with upregulation of AT1R and P2X 1 R are: (i) Ang II infusion resulted in AT1R and/or P2X1R desensitization or (ii) released Up 4 A in an Ang II-induced hypertensive model desensitized vascular P2X 1 R. Thus, we further determined the role of desensitization of AT1R and P2X 1 R in impaired aortic contraction in hypertensive mice.
Ang II-induced hypertension is a complex process involving AT1R desensitization, AT1R internalization, and activation of downstream pathways, such as reactive oxygen species and endothelin-1. 29, 33, 34, 40 Ang II-induced AT1R desensitization has been intensively reported in cardiovascular pathophysiology. 23, 40, 41 To study the possible effect of AT1R desensitization on Up 4 A-mediated vascular contraction, we carried out acute experiments in isolated aortas of control mice. AT1R desensitization, confirmed by the second Ang II exposure-induced noncontraction, failed to have an effect on Up 4 A-induced aortic contraction, suggesting that AT1R desensitization was not involved in the impaired Up 4 A-induced vascular contraction seen in Ang II-infused mice.
Up 4 A is endogenously released from the endothelium, and plasma levels of Up 4 A have been reported to be elevated in juvenile hypertensive patients. 5, 14 Purinergic receptor desensitization is also a common phenomenon when subjected to nucleotide stimulation. 42 Thus, desensitization of P2X 1 R is likely involved in impaired Up 4 A-induced vascular contraction. As expected, the aortic contraction induced by the second Up 4 A response was significantly reduced as compared to the first Up 4 A response in the same preparation. This was further evidenced by the vascular attenuation with P2X 1 R desensitizer α, β-methylene ATP. The similar effect of α, β-methylene ATP to desensitize P2X 1 R has also been shown in perfused rat kidney in response to Up 4 A. 10 Up 4 A-induced P2X 1 R desensitization may suggest a compensatory mechanism for purinergic receptors to counteract the hypervascular contractility present in hypertension. The possibility for Up 4 A to desensitize P2X 1 R may be present in vivo, as it is supported by the speculation that prolonged systemically in vivo Up 4 A infusion in rodent desensitizes purinergic receptors accounting for the lack of increase in blood pressure. 43 Similarly, in another study which was performed in afferent arteries of rat kidney showed that infusion of ATP or P2X 1 R agonist β, γ-methylene ATP results in a dose-dependent vasoconstriction, which was significantly impaired in Ang II-induced hypertension. 44 The attenuated P2X 1 R-mediated signaling could arise from chronic increases in renal interstitial ATP concentration in Ang II-infused rats leading to receptor desensitization. 45 Moreover, this evidence suggests that Up 4 A-desensitized P2X 1 R in mouse aorta may also exist in resistance vessel of our animal model, which warrants future investigations.
There is evidence that AT1R interacts with purinergic receptors increasing the diversity of signaling pathways and regulation of Ang II-AT1R. For instance, AT1R heterodimerizes with P2Y 6 R to promote Ang II-induced hypertension. 46 Belonging to ion channel receptors, P2X 1 R interacts with G protein-coupled receptor P2YR contributing to cardiovascular control and hemostasis. 47 Thus, it is reasonable to speculate that interaction of P2X 1 R with G protein-coupled receptor AT1R exists and P2X 1 R may play a compensatory role after AT1R is desensitized in Up 4 A-mediated vascular contraction. Further study confirming interaction between P2X 1 R and AT1R is warranted. Taken together, the findings from our acute experiments in control mice suggest that desensitized P2X 1 R but not AT1R may contribute to the impaired Up 4 A-induced vascular contraction observed in Ang II-infused mice and it maybe too early to draw a conclusion for the potential role of Up 4 A in development of hypertension.
Previously, we reported that Up 4 A-induced aortic contraction was endothelium-dependent. 15 Aortic endothelial dysfunction in Ang II-induced hypertensive mice has been extensively studied and reported. 48 Thus, endothelial dysfunction in Ang II-induced hypertensive mice may be involved in impaired Up 4 A-induced vascular contraction. Similar to other studies, 48 we observed that ACh-induced concentration-dependent aortic relaxation was reduced in our Ang II-induced hypertensive model. However, the maximal response to ACh (10 μM) was comparable to saline infusion (62.6 ± 4.5% vs. 53.3 ± 8.9%; P > 0.05). Along with the comparable single dose of ACh (1 μM)-induced aortic relaxation between saline-and Ang II-infused mice, our study suggested that reduced endothelial function was unlikely involved in the impaired response to Up 4 A in aortas from hypertensive mice. Nevertheless, the impact of endothelial dysfunction on Up 4 A-induced aortic contraction in Ang II-dependent hypertensive mice needs to be fully explored.
The catabolism of Up 4 A remains unclear. Previous reports showed that dinucleotides were mainly degraded to mononucleotides by ecto-nucleotidases such as NTPDase (also known as ecto-ATPDase CD39) and etco-5′-nucleotidase (CD37). This suggests that Up 4 A can also be degraded through those ecto-nucleotidases. However, reported observations demonstrated that Up 4 A increased perfused pressure in isolated kidney to a greater extent as compared to UTP or ATP, and showed a longer half-life than ATP 5, 8 ; Up 4 A exerted no tachyphylactic pattern in rat aortas 6 ; NTPDase inhibitor apyrase degraded UTP-and ATP-but not Up 4 A-mediated vascular smooth muscle migration. 49 Additionally, Zhou et al. showed that another NTPDase inhibitor ARL67156 did not affect Up 4 A-mediated vascular response in coronary arteries. 11 All these findings suggest that Up 4 A-mediated vascular effects are direct but are not through its degraded products or inhibition of purinergic enzymes. 50 In Ang II-infused animal model, one study showed an unchanged etco-5′-nucleotidase activity in kidneys of Ang II-infused rats, 51 suggesting an unaltered-regulation of nucleotidase. Thus, if there was degradation by nucleotidase, the Up 4 A degradation in saline-and Ang II-infused mice should be to a similar extent. However, the final vascular effect by Up 4 A or its degraded product depends on activation of receptors, e.g., purinergic receptors. In the present study, we found P2X 1 R is likely desensitized accounting for less contraction to Up 4 A. This suggests that P2X 1 R desensitization rather than amount of circulating Up 4 A or activity of nucleotidase may determine the role of Up 4 A in development of hypertension. Confirming the possibility of degradation in our animal model warrants further studies.
Study limitation
Up 4 A has been proposed to play a role in the development of hypertension. 5, 15, 38 In the present study, we further investigated vascular influence of Up 4 A in Ang II-induced hypertensive mice. We did not measure the plasma concentration of Up 4 A in our animal model. However, data from human studies showed an elevation of Up 4 A plasma level in juvenile hypertensive patients as compared to healthy subjects. 14 Moreover, Ang II activates endothelin-1 and circulating endothelin-1 is increased in both hypertensive animals and patients. 29, 52 Of note, endothelin-1 stimulates Up 4 A release from the endothelium. 5 Therefore, we speculate that the plasma Up 4 A level in our Ang II-infused mice is likely elevated.
To our knowledge, this is the first report where the AT1R protein expression has been measured in aortas of Ang II-infused mouse model. However, the specificity of the anti-AT1R antibody used in the present study has been challenged. 53 Alternatively, we performed additional experiments to measure AT1R mRNA expression in aortas of our models. We found that there is no significant difference in AT1R mRNA levels between saline-infused (0.16 ± 0.02, N = 4) and Ang II-infused aortas (0.14 ± 0.02, N = 5). The unchanged AT1R mRNA in aortas is consistent with findings in the kidney and liver of Ang II-infused rats. 54 There is still uncertainty regarding the effects of chronic Ang II infusion on AT1R expression, considering the duration and dose of Ang II infusion, level of increased blood pressure, and little evidence on the organ/speciesspecific regulation of the AT1R during Ang II infusion. 54 Future studies are required to confirm whether AT1R protein is indeed upregulated in vascular system of Ang II-infused models.
In summary, we demonstrated that Up 4 A-induced aortic contraction was surprisingly impaired in Ang II-induced hypertensive mice, despite increased blood pressure and upregulation of AT1R and P2X 1 R. The impaired Up 4 A effect was likely attributed to the desensitization of purinergic receptors (P2X 1 R), rather than AT1R observed in isolated aortas of control mice. Our findings imply that vascular purinergic receptor activity, rather than plasma Up 4 A levels, which may be elevated in hypertension, 14 may determine the role of Up 4 A in hypertension.
SUPPLEMENTARY MATERIAL
